Navigation Links
Stryker Hip Replacement Recall Lawyers at Wright & Schulte LLC Report on Growing Number of Stryker Hip Replacement Lawsuits
Date:8/18/2013

an R. Martinotti has designated a number of Stryker Rejuvenate hip replacement lawsuits for early mediation, and has ordered that a mediation session be held no later than December 15, 2013. Meanwhile, the federal multidistrict litigation is scheduled to hold its initial status conference on September 9, 2013.

According to the Stryker hip recall notice, some 20,000 Rejuvenate and ABG II hip stems were sold worldwide prior to the recall announcement in July 2012. The company has warned that the metal components may fret and corrode at the modular-neck junction, and possibly generate excessive amounts of metallic debris. This places recipients at risk for pain, swelling and adverse local tissue reactions. Plaintiffs in Stryker hip lawsuits have allegedly suffered metallosis, necrosis, osteolysis and other serious complications. According to their complaints, many of these patients have undergone revision surgery to have their failing Stryker hip removed, while others will likely need revision surgery in the future.
[literature.ortho.stryker.com/files/REJUV_COM_23.pdf]

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Stryker Rejuvenate and ABG II Modular-Neck Hip Replacement Stems lawsuits case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

Contact:
Wright Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-888-399-0795

'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Stryker Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Case Management Order in New Jersey Stryker Recall Litigation
2. Kershaw, Cutter & Ratinoff Launches Legal YouTube Video Blog to Assist Stryker Rejuvenate Recall Victims Nationwide
3. Stryker Lawsuits Move Forward in New Jersey Superior Court, as Bernstein Liebhard LLP Notes Upcoming Case Management Conference
4. Stryker Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of Protective Order in New Jersey Stryker Hip Recall Litigation
5. Stryker Hip Lawsuits Proceed in New Jersey Litigation as Court Issues New Case Orders, Reports Wright & Schulte
6. Stryker Lawsuit News: Bernstein Liebhard LLP Notes New Order in New Jersey Stryker Recall Litigation
7. Stryker Recall News: Filings Mount in New Jersey Litigation Established for Stryker Hip Lawsuits, Bernstein Liebhard LLP Reports
8. Rottenstein Law Group LLP Announces Launch of Stryker Lawsuit Center
9. Florida Man Says Stryker’s Rejuvenate Hip Implant is Defective, Causing him Serious Injuries, Need for Revision Surgery, Alleges Lawsuit Filed by Parker Waichman LLP
10. Tennessee Woman Implanted with Stryker Metal Hip Stem Suffered Serious Injuries, Plus Need for Revision Surgery, Alleges Lawsuit Filed by Parker Waichman LLP
11. Stryker Hip Recall Litigation Moves Forward in New Jersey with Issuance of New Order, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... December 26, 2014 DW-InductionHeating.com (DaWei Induction ... designing, researching and developing, producing and marketing of a ... the business announces their new series of induction ... of the company, induction brazing refers to ... special filler material and heat. The manager says that ...
(Date:12/25/2014)... 26, 2014 The report “Nintedanib ... 2023” focuses on the current treatment landscape, unmet ... colorectal cancer market. Stivarga is a drug which ... rectal cancer. Boehringer Ingelheim is developing nintedanib (BIBF-1120), ... of refractory CRC in the US, Europe, and ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 Recently, Dylan ... dresses, has excitedly released its collection of discounted prom ... to Percy, a senior spokesman of the company, the ... of this promotion is to expand the UK market. ... in several different colors, lengths, and styles: A-line strapless, ...
(Date:12/25/2014)... Miami, FL (PRWEB) December 25, 2014 When ... often find themselves in a frenzy to get rid of ... classroom. But families in Coral Gables now have the solution ... its second salon clinic location, Lice Troopers provides full spectrum ... in the Coral Gable area, including Sunset, Key Biscayne, Brickell, ...
(Date:12/25/2014)... -- Among early stage breast cancer patients who undergo ... percent will eventually develop leukemia as a result of ... comes from a review of more than 20,000 breast ... suggests that the risk for developing treatment-related leukemia, though ... "The frequency of bone marrow cancers such as ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... first time to date, research published in the October ... sought to determine the use of chemotherapy in ... encompassing all patient ages. Prior population-based studies have shown ... cancer patients receive chemotherapy treatment. These studies have previously ...
... Researchers from the Arkansas Epilepsy Program found treatment with ... compared with placebo, for patients with uncontrolled partial-onset seizures ... in Epilepsia , a journal published by Wiley-Blackwell ... Epilepsy affects up to 2% of the worldwide ...
... papillomavirus (HPV) DNA-based testing or visual inspection of the ... had a statistically significant reduction in high grade cervical ... according to a study published online Sept. 30 in ... In many developing countries, especially in ...
... of Health scientists could explain how Salmonella bacteria, a ... In a study published this week in the ... describe finding a reservoir of rapidly replicating Salmonella inside ... cells and are pushed from the epithelial layer by ...
... MEDFORD/SOMERVILLE, Mass.--Researchers from Tufts University School of Engineering and ... precursors to the potent anti-cancer compound Taxol in an ... The findings are significant steps on the way to ... to design new Taxol-like pharmaceuticals. The work ...
... Louisville School of Nursing has earned a $792,000 grant ... Health Resources and Services Administration to develop nursing informatics ... well as practicing nurses from University of Louisville Hospital. ... a tsunami of patient data in order to make ...
Cached Medicine News:Health News:New lung cancer research finds half of advanced lung cancer patients receive chemotherapy 2Health News:Adjunctive rufinamide reduces refractory partial-onset seizures 2Health News:HPV screen-and treat-intervention effective in cervical cancer prevention 2Health News:NIH scientists describe how salmonella bacteria spread in humans 2Health News:Researchers advance biosynthesis of potent anti-cancer drug Taxol 2Health News:UofL School of Nursing awarded grant to fund new informatics education project 2
(Date:12/24/2014)... -- The International Trade Commission (ITC) issued its final decision in ... a notice issued on December 23, the ITC ruled in ... humidifier was invalid. BMC President, James Xu ... excited with the ITC,s decision in this case. This victory ... the very beginning on the key patents in the case. ...
(Date:12/24/2014)... -- PuraMed BioScience®, Inc., (OTC Pink: PMBS), a researcher, ... products, announced it received the initial funding to begin ... relief product, for planned distribution to 1,000 medical and ... Washington State , and ... Advanced headache relief gel formulation completed, PuraMed BioScience has ...
(Date:12/24/2014)... Mass. , Dec. 23, 2014   ... ), a biopharmaceutical company developing therapeutic products for ... Medicines Agency (EMA) of the Marketing Authorization Application ... EMA recently granted the company,s request for accelerated ... EMA,s regulatory review time.   The ...
Breaking Medicine Technology:ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3
... SANTA ROSA, Calif. , Feb. 16 Osseon Therapeutics ... Europe . The procedures were performed in Milan, Italy ... largest independent medical device distributor in Europe , Osseoplasty cases ... United Kingdom , Germany and Spain . ...
... , CRANBURY, N.J. , Feb. 16 ... the fourth quarter and full year 2009.  The Company also provided ... key strategic priorities for 2010.  Additionally, the Company stated that it ... completing enrollment for its Phase 3 study of Amigal ™ ...
Cached Medicine Technology:Osseon Launches in Europe 2Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 2Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 3Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 4Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 5Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 6Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 7Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 8Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 9Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 10Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements 11
... with blade. Fiberoptic blades are designed ... allowing you to take advantage of ... from different fitting fiberoptic systems. FOCS™ ... cost effective alternative to expensive fiberoptic ...
... can be used with Portex® reusable or ... blades with long-lasting bronze fiber-optic bundles provide ... routine use., ,The laryngoscope blades are ... from infant to large adult, and in ...
... system. Providing an unobstructed view of the ... many types of intubations., ,A high ... patented Glidescope blade. Clear images are captured ... monitor screen. An LED light source mounted ...
... Tip Laryngoscopes are the most ... The articulating tip aids during ... improved view of epiglottis. Available ... styles. We guarantee your complete ...
Medicine Products: